Seroprevalence results for M. leprae antibodies in children without leprosy sorted per country.

Overview per country of the information gathered from the studies included in this review reporting data on serology for M. leprae-specific antigens. For each study, the country/area, reference number, author, year of publication, test group, age (range), number of children, prevalence of seropositivity (%) for M. leprae antibodies, sample, test target and laboratory assay are reported. *Estimated from graph/figure. Ab: antibody; CP: contact population from a leprosy colony; ELISA: enzyme-linked immunosorbent assay; F: females; GPAT: gelatin particle agglutination test; HER: children from reported high-endemic region; IgA: immunoglobulin A; IgG: immunoglobulin G; IgM: immunoglobulin M; LER: children from reported low-endemic region; LID-1: leprosy IDRI diagnostic-1; M: males; (N)D-O-BSA: (natural) disaccharide-octyl bovine serum albumin; ND-O-HSA: natural disaccharide-octyl human serum albumin; ND-O-LID: semi-synthetic disaccharide attached to the octyl radical, which mimics PGL-I, conjugated with two fusion proteins, ML0304 and ML0331, forming LID; NTO: natural trisaccharide-octyl; NT-P-BSA: natural trisaccharide phenylpropionyl bovine serum albumin; PGL-I: phenolic glycolipid-I; ref. no.: reference number; UCP-LFA: up-converting phosphor lateral flow assay. (XLSX)